W. Karl

611 citations
23 papers · 467 · h-index 13

Impact in

Papers in

    • Cancer therapeutics and mechanisms 2
    • Pharmacogenetics and Drug Metabolism 6
    • Microbial Natural Products and Biosynthesis 2

W. Karl

21 papers receiving 447 citations

Peers

W. Karl
Comparison fields: 5 of 79
  • Pollution 135
  • Molecular Medicine 45
  • Pharmacology 112
  • Biotechnology 55
  • Pharmacology 50
Replace L. Turco with:
L. Turco Italy
Sara Cravo Portugal
Burton H. Jaynes United States
Luigia Merone Italy
A. L. LABORDE United States
Rizwana Sarwar Pakistan
Miloš Petković Serbia
Ryosaku Nomi Japan
Sachin B. Agawane India
Pradeepraj Durairaj China
W. Karl relative to L. Turco Italy L. Turco's profile →
Citations per field
00.5×5.6×
L. Turco · 1×
Citations per year

Countries citing papers authored by W. Karl

Since Specialization
Citations

This map shows the geographic impact of W. Karl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Karl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Karl more than expected).

Fields of papers citing papers by W. Karl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Karl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Karl. The network helps show where W. Karl may publish in the future.

Co-authors

The 25 scholars most cited alongside W. Karl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Karl Line = papers co-authored together W. Karl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 199799
2 200548
3 200546
4 201143
5 200532
6
Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
198830
7 201026
8 197622
9 200818
10
Biotransformation of nimodipine in rat, dog, and monkey.
199118
11
Nitrendipine: identification and synthesis of main metabolites.
198317
12 200114
13 200513
14
Biotransformation of nifedipine in rat and dog.
199211
15 20029
16 20008
17
Biotransformation of nitrendipine in rat, dog, and mouse.
19917
18 20032
19 19891
20 20021

About W. Karl

W. Karl is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Computer Networks and Communications and Electrical and Electronic Engineering, having authored 23 papers that have together received 467 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Chemical Reactions and Isotopes (3 papers), Parallel Computing and Optimization Techniques (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Oral and gingival health research (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Cancer therapeutics and mechanisms (2 papers) and Distributed and Parallel Computing Systems (2 papers). The work is most often cited by research in Pollution (135 citations), Molecular Medicine (45 citations), Pharmacology (112 citations), Biotechnology (55 citations) and Pharmacology (50 citations). W. Karl has collaborated with scholars based in Germany, United Kingdom and Austria. Frequent co-authors include Heinz-Georg Wetzstein, N. Schmeer, Josef Schneider, H J Ahr, Doris Ribitsch, Peter Remler, Karl Gruber, Helmut Schwab, E Wehinger and G. Ahr. Their work appears in journals such as Applied Microbiology and Biotechnology, Journal of Biotechnology, Applied and Environmental Microbiology, Tetrahedron Letters and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact